|
CN111655296A
|
|
Improved nucleotide sequence encoding peptide linker
|
|
BR112020015991A2
|
|
METHODS OF TREATING INITIAL TTP EPISODE WITH SINGLE VARIABLE DOMAINS OF IMMUNOGLOBULIN
|
|
EP3636657A1
|
|
Chromatography-free antibody purification method
|
|
AR112069A1
|
|
IMMUNOGLOBULINS THAT BIND AGGRECAN
|
|
SG11201908154RA
|
|
Improved immunogenicity assays
|
|
US2019367597A1
|
|
Serum albumin binders
|
|
EP3571224A1
|
|
Improved serum albumin binders
|
|
EP3551656A1
|
|
Improved serum albumin binding immunoglobulin single variable domains
|
|
WO2018099968A1
|
|
Treatment of infection by respiratory syncytial virus (rsv)
|
|
WO2018091606A1
|
|
T cell recruiting polypeptides capable of binding cd123 and tcr alpha/beta
|
|
EP3512880A1
|
|
Immunoglobulin single variable domains directed against macrophage migration inhibitory factor
|
|
WO2018029182A1
|
|
Il-6r single variable domain antibodies for treatment of il-6r related diseases
|
|
WO2018007442A1
|
|
Treatment of il-6r related diseases
|
|
AU2017281421A1
|
|
Improved pharmacokinetic assays for immunoglobulin single variable domains
|
|
AU2017259876A1
|
|
Treatment of RSV infection
|
|
CN108699151A
|
|
The method for being used to prepare immunoglobulin (Ig) list variable domains
|
|
SG11201803976VA
|
|
Polypeptides inhibiting cd40l
|
|
CN108473564A
|
|
Improved seralbumin bonding agent
|
|
BR112018009714A2
|
|
improved tnf binders
|
|
CA3005082A1
|
|
Improved p2x7 receptor binders and polypeptides comprising the same
|
